Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
New Gold Opportunities in the Cariboo Region (CSE:GCC) (OTC:GCCFF) (click to learn more) Why Herbal Dispatch (CSE:HERB) Is Getting Attention (click to learn more) Atlas Salt Expands MOU with Sandvik Mining Supporting Great Atlantic Salt Project (click to learn more) Digital Health Meets AI -CSE: ALEN.U (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Precigen Inc PGEN

Healthcare Biotechnology
Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. It operates through two segments, Biopharmaceuticals and Exemplar. The company offers therapeutic platforms consisting of AdenoVerse platform, which utilizes a library... see more

Current News (NDAQ:PGEN)

Precigen Reports Third Quarter 2025 Financial Results and Business Updates

PR Newswire November 13, 2025

Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13

PR Newswire November 6, 2025

Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis

PR Newswire October 13, 2025

Precigen Announces Up to $125 Million Non-Dilutive Financing

PR Newswire September 3, 2025

Precigen to Participate in Upcoming Virtual Fireside Chats Hosted by Cantor and H.C. Wainwright

PR Newswire August 25, 2025

Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis

PR Newswire August 15, 2025

Precigen Reports First Quarter 2025 Financial Results and Business Updates

PR Newswire May 14, 2025

Precigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th

PR Newswire April 16, 2025

Precigen Reports Full Year 2024 Financial Results and Business Updates

PR Newswire March 19, 2025
View More News ››

Opinion & Analysis (NDAQ:PGEN)

Investment in cell and gene therapies ramps up

The Life Sciences Report June 8, 2016

CAR T-cell therapeutics: Alan Leong of BioWatch looks beyond the buzz for solid early-stage plays

Gail Dutton September 10, 2015
View More Opinion ››

Bullboard Posts (NDAQ:PGEN)

Using technical analysis for this stock.

It is starting to show strength to the upside and should do well as a buy and hold position
coolfooldumbguy - August 18, 2025

Precigen, Inc. (NASDAQ:PGEN): Advancing Precision Medicine w

http://beyondspx.com/2024/08/01/precigen-inc-nasdaqpgen-advancing-precision-medicine-with-innovative-gene-and-cell-therapies/
MikeTester - August 2, 2024

Q4 results

soon /
SusanBolland - January 19, 2022

XON Trade Signals

XON stock fell by 5% in the market on July 16th.  However, XON trade signals verified a buy signal two weeks in advance, which...
BluSignals - July 16, 2018

this one is doing well

for me today,the oil plays are getting sold off for profit taking,glad to diversify,so glta.
coolfooldumbguy - July 12, 2018

bought this one today

at $14.90 per share after seeing the insiders load up shares last week,great future ahead of it, looks like an upswing started here,so...
coolfooldumbguy - July 10, 2018
View more Bullboard ››

Spanish Mountain Gold Ltd.

Spanish Mountain Gold Ltd.

Spanish Mountain Gold Ltd., an exploration and development stage company, engages in the acquisition, exploration, and ...
View More »

Podcasts